The present invention provides novel complexes consisting of certain GLP-1
molecules associated with a divalent metal cation that is capable of
co-precipitating with a GLP-1 molecule. Pharmaceutical compositions and
methods of using such complexes for enhancing the expression of insulin in
B-type islet cells is claimed, as is a method for treating maturity onset
diabetes mellitus in mammals, particularly humans.
